AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 180 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,511,000 | -55.6% | 62,507 | -12.8% | 2.71% | -52.4% |
Q1 2019 | $3,405,000 | +64.1% | 71,675 | +24.7% | 5.69% | -0.8% |
Q4 2018 | $2,075,000 | -53.8% | 57,486 | -21.2% | 5.73% | +38.2% |
Q3 2018 | $4,491,000 | +33.6% | 72,970 | +46.7% | 4.15% | +25.6% |
Q2 2018 | $3,361,000 | -11.1% | 49,756 | -28.6% | 3.30% | -30.1% |
Q1 2018 | $3,780,000 | +56.8% | 69,676 | +72.8% | 4.73% | +44.5% |
Q4 2017 | $2,410,000 | +175.7% | 40,330 | +124.4% | 3.27% | +222.6% |
Q3 2017 | $874,000 | -34.7% | 17,975 | -29.4% | 1.01% | -36.1% |
Q2 2017 | $1,338,000 | -39.5% | 25,464 | -47.8% | 1.59% | -48.6% |
Q1 2017 | $2,213,000 | -8.8% | 48,800 | -23.9% | 3.08% | -31.6% |
Q4 2016 | $2,426,000 | -57.3% | 64,095 | -57.5% | 4.51% | -54.4% |
Q3 2016 | $5,686,000 | +284.4% | 150,651 | +79.3% | 9.89% | +265.0% |
Q2 2016 | $1,479,000 | -13.5% | 84,026 | -40.2% | 2.71% | -39.2% |
Q1 2016 | $1,710,000 | -18.3% | 140,587 | +63.7% | 4.46% | +40.9% |
Q4 2015 | $2,092,000 | +37.4% | 85,895 | +0.1% | 3.16% | -6.8% |
Q3 2015 | $1,523,000 | – | 85,834 | – | 3.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 1,464,749 | $98,944,000 | 34.86% |
Foresite Capital Management III, LLC | 1,708,046 | $115,379,000 | 24.85% |
Eversept Partners, LP | 226,902 | $15,327,230 | 7.01% |
SECTORAL ASSET MANAGEMENT INC | 615,870 | $41,602,000 | 4.65% |
DAFNA Capital Management LLC | 131,770 | $8,901,000 | 4.17% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 68,666 | $4,638,000 | 3.67% |
Asymmetry Capital Management, L.P. | 49,756 | $3,361,000 | 3.30% |
PFM Health Sciences, LP | 2,720,218 | $183,751,000 | 2.88% |
HealthCor Management, L.P. | 1,314,290 | $88,780,000 | 2.82% |
Boulegeris Investments, Inc. | 66,540 | $4,495,000 | 2.25% |